Diabetes, glycemic control, and risk of tuberculosis: A population-based case-control study

Diabetes Care

Volumn 34, Issue 12, 2011, Pages 2530-2535

  Leegaard, Anne ^a   Riis, Anders ^a   Kornum, Jette B ^a   Prahl, Julie B ^b   Thomsen, Vibeke Ø ^b   Sørensen, Henrik Toft ^a,c   Horsburgh, C Robert ^c   Thomsen, Reimar W ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GLUCOSE; HEMOGLOBIN A1C; IMMUNOSUPPRESSIVE AGENT; INSULIN; ORAL ANTIDIABETIC AGENT; PROTON PUMP INHIBITOR; TUBERCULOSTATIC AGENT;

ADULT; AGED; ALCOHOLISM; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; FEMALE; GLYCEMIC CONTROL; HUMAN; IMMIGRANT; INFECTION RISK; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; SOCIAL STATUS; TUBERCULOSIS; CASE CONTROL STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; MIGRATION; RISK; STATISTICS;

ADULT; AGED; BLOOD GLUCOSE; CASE-CONTROL STUDIES; COMORBIDITY; DENMARK; DIABETES COMPLICATIONS; DIABETES MELLITUS; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK; TUBERCULOSIS;

EID: 84860853632     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-0902     Document Type: Article

References (25)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053 (Pubitemid 38579764)
2. Creswell J, Raviglione M, Ottmani S, et al. Tuberculosis and noncommunicable diseases: neglected links and missed opportunities. Eur Respir J 2011;37:1269-1282
3. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009;9:737-746
4. Root H. The Association of Diabetes and Tuberculosis. N Engl J Med 1934;210:1-13
5. Peleg AY, Weerarathna T, McCarthy JS, DavisTME. Common infections indiabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 2007;23:3-13 (Pubitemid 46152480)
6. Stegenga ME, van der Crabben SN, Blümer RME, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 2008;112:82-89
7. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, Sørensen HT. Diabetes, glycemic control, and risk of hospitalization with pneumonia: a populationbased case-control study. Diabetes Care 2008;31:1541-1545
8. Leung CC, Lam TH, Chan WM, et al. Diabetic control and risk of tuberculosis: a cohort study. AmJ Epidemiol 2008;167:1486-1494
9. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008;5:e152
10. Pablos-Méndez A, Blustein J, Knirsch CA. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health 1997;87:574-579 (Pubitemid 27208742)
11. Health care in Denmark [article online], 2008. Copenhagen, Denmark, Ministry of the Interior and Health. Available from http://www.sum.dk/Aktuelt/ Publikationer/Publikationer/UK-Healthcare-in-DK.aspx. Accessed 29 July 2011
12. SeersholmN, Andersen PH, Andersen AB, et al. Tuberculosis control in Denmark: a national tuberculosis program [article online], 2010. Copenhagen, Denmark, Danish Society of Respiratory Medicine. Available from http://www.lungemedicin.dk/side2.html. Accessed 29 July 2011
13. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263-268 (Pubitemid 29299976)
14. European Centre for Disease Prevention and Control (ECDC)/WHO Regional Office for Europe. Tuberculosis Surveillance in Europe 2008. Stockholm, Sweden, European Centre for Disease Prevention and Control (ECDC)/WHO Regional Office for Europe, 2010
15. Andersen PH, Kjelsø C. Tuberculosis 2008, Part I [article online], 2009. Copenhagen, Denmark, Statens Serum Institut. Available from http://www.ssi.dk/English/News/EPINEWS/2009.aspx. Accessed 29 July 2011
16. Ehrenstein V, Antonsen S, Pedersen L. Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin Epidemiol 2010;2:273-279
17. Stevenson CR, Critchley JA, Forouhi NG, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn 2007;3:228-245 (Pubitemid 351927860)
18. Marks G, Dobler C, Flack J. Estimation of the risk of tuberculosis among people with diabetes (Abstract). Eur Respir J 2009;34(Suppl. 53):2549
19. Marks SM. Diabetes and tuberculosis, US National Health Interview Survey, 2000-2005. Int J Tuberc Lung Dis 2011;15:982-984
20. Bang D, Andersen AB, Thomsen VO, Lillebaek T. Recurrent tuberculosis in Denmark: relapse vs. re-infection. Int J Tuberc Lung Dis 2010;14:447-453
21. Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005;41:281-288 (Pubitemid 41022101)
22. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003;26:510-513 (Pubitemid 36929083)
23. Thomsen RW, Hundborg HH, Lervang HH, Johnsen SP, Schønheyder HC, Sørensen HT. Risk of community-acquired pneumococcal bacteremia in patients with diabetes: a population-based case-control study. Diabetes Care 2004;27:1143-1147 (Pubitemid 38579780)
24. Sugawara I, Mizuno S. Higher susceptibility of type 1 diabetic rats to Mycobacterium tuberculosis infection. Tohoku J Exp Med 2008;216:363-370
25. Yamashiro S, Kawakami K, Uezu K, et al. Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin- induced diabetes mellitus infected with Mycobacterium tuberculosis. Clin Exp Immunol 2005;139:57-64 (Pubitemid 40066129)